$45M sweet spot round size
Most of their 69 investments are in rounds between $23M and $67M
2001
ReCode Therapeutics raised $50M on September 19, 2023
Investors: OrbiMed Advisors, Solasta Ventures, Vida Ventures, LLC, Leaps by Bayer, Osage University Partners (OUP), MPM Capital and Sanofi Ventures
ROME Therapeutics raised $72M on September 12, 2023
Investors: Bristol-Myers Squibb, UK, GV, Section 32, Casdin Capital, LLC and Sanofi Ventures
VERALOX Therapeutics raised $24M on June 20, 2023
Investors: JDRF T1D Fund, Genesys Capital, Pappas Capital, NYBC Ventures and Sanofi Ventures
Therini Bio, Inc. (formerly MedaRed, Inc.) raised $36M on April 27, 2023
Investors: The Dementia Discovery Fund, SV Life Sciences, Dolby Family Ventures and Sanofi Ventures
QurAlis raised $88M on March 9, 2023
Investors: Life Sciences Partners (LSP), MP Healthcare Venture Management Inc, Mission Bay Capital, EQT Life Sciences, Mission BioCapital, Inkef and Sanofi Ventures
Avilar Therapeutics raised $15M on February 16, 2023
Investors: Astellas Venture Capital L.L.C., RA Capital Management, L.P., Medical Excellence Capital, LLC and Sanofi Ventures
NextPoint Therapeutics, Inc. raised $80M on January 10, 2023
Investors: Catalio Capital Management, Sixty Degree Capital, Leaps by Bayer, MPM Capital, The Invus Group and Sanofi Ventures
Undisclosed raised $23M on December 15, 2022
Investors: Pureos Bioventures, REPAIR Impact Fund, Adjuvant Capital, Industrifonden, Wellington Partners, Sunstone Life Science Ventures, Trill Impact and Sanofi Ventures
Escient Pharmaceuticals raised $120M on November 28, 2022
Investors: Osage University Partners (OUP), Redmile Group, The Column Group, Avego Healthcare Capital, The Eleven Fund, Partner Fund Management and Sanofi Ventures
Normunity raised $65M on October 25, 2022
Investors: Osage University Partners (OUP), Canaan and Sanofi Ventures